MedTrace Logo

The Tetrad BMI, Leptin, Leptin/Adiponectin (L/A) Ratio and CA-15-3 is a Reliable Biomarker of Breast Cancer

NCT01643148 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 88

Last updated 2012-07-18

No results posted yet for this study

Summary

Objective:

Evaluate body mass index (BMI), leptin, Leptin/adiponectin (L/A) ratio and cancer antigen (CA) 15-3 together as reliable biomarkers for breast cancer.

Patients:

Consecutive patients aged between 40 - 60 years, with breast disease and informed consent.

Interventions:

Patients' Anthropometric and laboratorial characteristics classified by BMI in the group of cancer and patients with benign breast disease as well as biochemical tests of leptin, adiponectin,CA 15-3, hemoglobin, glucose low-density lipoprotein cholesterol (LDLC), high-density lipoprotein cholesterol (HDLC) levels were obtained as well as a blood sample to analyze CA 15-3 levels with a electrochemiluminescence immunoassay.

Hypothesis:

Using together leptin, L/A ratio, CA 15-3 and BMI could offer a reliable approach to detect high risk women to develop breast cancer.

Conditions

  • Female Breast Carcinoma

Sponsors & Collaborators

  • Universidad Autonoma del Estado de Mexico

    collaborator OTHER

  • Materno-Perinatal Hospital of the State of Mexico

    lead OTHER

Principal Investigators

  • Jonnathan Guadalupe Santillán Benítez, MSc · Autonomus University Of the State Of México

  • Leobardo Manuel Gómez Oliván, PhD · Universidad Autonoma del Estado de Mexico

  • Hugo Mendieta Zeron, PhD · Autonomous University of the State of Mexico

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2011-10-31
Completion
2012-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01643148 on ClinicalTrials.gov